Benign lung nodules can and do light up on PET scans. A PET scan works by detecting cells that consume large amounts of glucose, and while cancer cells are famously hungry for sugar, they are not the only ones. Infections, inflammation, and certain immune responses also drive glucose uptake high enough to produce a bright spot that looks suspicious. The result is a well-recognized problem in radiology: false positives that send patients down a stressful path of further testing for what turns out to be harmless.
Why Some Benign Nodules Show Up
The standard PET scan used to evaluate lung nodules relies on a radioactive sugar tracer called FDG (fluorodeoxyglucose). Cells that are metabolically active absorb more of this tracer, and the scanner picks up the signal. Cancer cells tend to be very metabolically active, which is why PET scans are useful for spotting malignancy. But any process that revs up cellular metabolism can produce a similar signal. Activated immune cells, for instance, consume glucose at high rates when they are fighting an infection or mounting an inflammatory response. Granulomas, sarcoidosis, and other inflammatory conditions can all cause a nodule to light up on PET, mimicking cancer.
Doctors quantify the brightness of a spot on a PET scan using a number called the SUV, or standardized uptake value. An SUV of 2.5 or higher has been widely used as a threshold suggesting malignancy. In one study comparing malignant and benign nodules, malignant lesions had a mean SUV of 4.7 while benign lesions averaged 1.08, and at the 2.5 cutoff the scan had perfect specificity in that particular dataset, meaning no benign nodule crossed the line.1PubMed. Solitary pulmonary nodules: morphological and metabolic characterisation by FDG-PET-MDCT But that kind of clean separation does not hold across all settings, and it is the exceptions that make this question so important for patients.
When the 2.5 Cutoff Fails
The 2.5 SUV threshold is a useful starting point, but its reliability depends heavily on how big the nodule is. A study that grouped nodules by size found that for very small nodules (1 cm or under), the sensitivity was about 85% but the specificity dropped to just 36%. That means roughly two out of three benign sub-centimeter nodules that happened to cross the 2.5 line were being flagged as suspicious. Specificity improved somewhat for larger nodules but never became airtight, reaching only 47% for nodules between 1.1 and 2.0 cm and falling to 17% for nodules over 3.0 cm.2PubMed Central. Relation between nodule size and 18F-FDG-PET SUV for malignant and benign pulmonary nodules In other words, the 2.5 cutoff is far from a clean dividing line, and the smaller the nodule, the less meaningful the number becomes.
Part of the problem is physics. PET scanners have limited spatial resolution, and when a nodule is very small, the scanner underestimates how much tracer is actually concentrated there. This is called the partial-volume effect: the signal from a tiny hot spot gets averaged with the surrounding cold tissue, dragging the measured SUV down.3PubMed Central. The value of 18F-FDG PET/CT in the diagnosis of different size of solitary pulmonary nodules Lesions under about 7 mm are only visible when the metabolic activity is very high.4Journal of Nuclear Medicine. Accuracy of PET/CT in Characterization of Solitary Pulmonary Lesions So for the smallest nodules, a negative PET scan does not reliably rule out cancer, and a positive one may reflect inflammation rather than malignancy. This is one reason guidelines typically recommend surveillance CT scans rather than PET for the smallest incidental nodules.
The Biggest Culprits Behind False Positives
Not all benign causes of a hot PET scan are created equal. Some are far more common offenders than others, and knowing which ones tend to fool the scanner helps explain why false positives cluster in certain patient populations.
Infections top the list. A retrospective analysis of false positive PET-CT diagnoses in lung patients found that inflammatory pseudotumor and tuberculoma were the most common benign pathologies mistaken for cancer, accounting for roughly 43% and 37% of false positives, respectively.5PubMed Central. Retrospective analysis for the false positive diagnosis of PET-CT scan in lung cancer patients Active tuberculosis, fungal infections like histoplasmosis, and bacterial pneumonia can all produce nodules that light up brightly because the immune cells packed into those lesions are burning through glucose. Histoplasmosis in particular has been documented producing false-positive PET results that initially looked like metastatic cancer in both pediatric and young adult patients.6PubMed. Pseudometastasis secondary to histoplasmosis infection: false-positive PET/CT findings
Granulomatous conditions are another major source of confusion. These involve clumps of immune cells forming nodules in the lungs, and they are metabolically active enough to cross the 2.5 threshold with ease. Sarcoidosis is a classic example, but granulomas also form in response to foreign materials. Silicone-induced granulomas, for instance, have been reported masquerading as malignancy on PET scans.7PubMed Central. Not All That Shines on a PET Scan Is Cancer: A Silicone-Induced Granuloma Masquerading as Malignancy Rheumatoid nodules in patients with rheumatoid arthritis can similarly cause increased uptake, creating genuine diagnostic dilemmas when a lung nodule is found incidentally in someone being evaluated for something else.8PubMed Central. Role of (18)F-FDG PET Scan in Rheumatoid Lung Nodule: Case Report and Review of the Literature
Why Where You Live Matters
The false positive problem is not evenly distributed around the world. A meta-analysis published in JAMA found that PET scans had about 16% lower specificity in regions where infectious lung diseases like tuberculosis and histoplasmosis are endemic compared to regions where those infections are uncommon. Specificity averaged around 61% in endemic areas versus 77% in non-endemic areas.9PubMed Central. Accuracy of FDG-PET to diagnose lung cancer in areas with infectious lung disease: A meta-analysis If you live in the Ohio River Valley of the United States, parts of Southeast Asia, sub-Saharan Africa, or other regions where fungal or mycobacterial lung infections are common, the chance of a benign nodule lighting up on your PET scan is meaningfully higher than published averages would suggest.
This geographic wrinkle is something many patients do not hear about. A PET scan report showing an SUV of 3.5 means something different for a patient in a region rife with histoplasmosis than for one in a low-endemic area. Doctors practicing in endemic zones are generally aware of this, but patients who have moved or traveled may not think to mention it, and the radiologist reading the scan may not know the patient’s full geographic history.
Breathing and Other Technical Artifacts
There is also a purely technical reason benign lung tissue sometimes looks suspicious on PET. The CT portion of a PET-CT scan is typically acquired during a breath hold, while the PET portion is captured over several minutes of normal breathing. Because the lungs move substantially with each breath, a nodule can end up in slightly different positions on the two scans. When the computer fuses these images together, that mismatch can place high metabolic activity from normal tissue directly over a nodule, making it appear to light up when it actually does not.10PubMed Central. Causes and imaging features of false positives and false negatives on 18F-PET/CT in oncologic imaging Experienced radiologists look for this pattern, but it is another layer of ambiguity that can make a benign nodule look worrisome.
Dual-Time-Point Scanning
One technique designed to help sort benign from malignant nodules involves scanning the patient twice, usually about an hour apart. The idea is straightforward: cancer cells tend to keep accumulating FDG over time, so their SUV goes up on the second scan, while many inflammatory lesions plateau or even decrease. A study of this dual-time-point approach found that standard single-scan PET at the 2.5 threshold achieved 80% sensitivity and 94% specificity, while dual-time-point scanning (using a threshold of 10% increase between scans) reached 100% sensitivity with 89% specificity.11Journal of Nuclear Medicine. Dual Time Point 18F-FDG PET for the Evaluation of Pulmonary Nodules
A separate study specifically looked at nodules that fell below the 2.5 cutoff on the first scan. Adding a delayed scan correctly identified three additional malignant nodules that had initially been read as benign, without producing any new false positives among the benign nodules.12PubMed Central. The value of delayed (18)F FDG-PET imaging in diagnosis of solitary pulmonary nodules: A preliminary study on 28 patients The catch is that dual-time-point imaging requires the patient to stay longer, uses more scanner time, and is not universally available. It tends to be used selectively, often when the initial result is ambiguous and the clinical team wants more data before recommending biopsy.
What Happens After a Positive PET Result
A PET scan that lights up does not automatically mean surgery. Clinicians typically weigh the PET result against patient history, nodule characteristics on CT (size, shape, edge patterns, growth rate), and risk factors like smoking history and age. In one study of patients whose nodules were flagged during low-dose CT screening, about half had their PET scans read as benign and were either followed with repeat imaging or received no further workup. Among the roughly half whose scans were indeterminate or suggested malignancy, biopsy was performed in the large majority.13PubMed Central. Utility of FDG PET/CT for assessment of lung nodules identified during low dose computed tomography screening
Biopsy remains the definitive answer when imaging is uncertain. In a head-to-head comparison of PET and contrast-enhanced CT, qualitative PET interpretation was positive in 24 of 25 malignant nodules but also lit up in 4 of 17 benign ones.14PubMed. Characterization of the solitary pulmonary nodule: 18F-FDG PET versus nodule-enhancement CT That means nearly one in four of the benign nodules in that dataset were PET-positive. In another surgical series, six out of eight patients whose biopsies came back benign had positive PET-CT scans beforehand.15PubMed. Role of positron emission tomography scanning in the management of lung nodules detected at baseline computed tomography screening These numbers reinforce why a lit-up PET scan alone is not a cancer diagnosis.
Newer Tracers and Computer-Aided Tools
The limitations of FDG have pushed researchers toward alternative PET tracers that target features more specific to cancer. One such tracer, FLT (fluorothymidine), tracks cell proliferation rather than general glucose metabolism. Because rapidly dividing cancer cells take up FLT much more than inflammatory cells do, combining FLT with FDG data can sharpen the distinction between benign and malignant nodules. A study evaluating radiomic models built from both FDG and FLT PET data found that the combined approach outperformed FDG alone, with an area under the curve of 0.838 versus 0.810 and improved specificity.16PubMed Central. Radiomic analysis will add differential diagnostic value of benign and malignant pulmonary nodules: a hybrid imaging study based on [(18)F]FDG and [(18)F]FLT PET/CT Other tracers targeting amino acid metabolism, tumor hypoxia, and even cancer-associated fibroblasts are in various stages of development.17PubMed Central. Positron emission tomography imaging of lung cancer: An overview of alternative positron emission tomography tracers beyond F18 fluorodeoxyglucose None have replaced FDG in routine clinical practice yet, but they represent a shift toward more cancer-specific imaging.
Computer-aided diagnosis is another active frontier. A semiautomatic system that combined clinical parameters, CT features, and PET features achieved an area under the curve of 0.95, compared to 0.83 for CT-based features alone and 0.91 for PET-based features alone.18Journal of Nuclear Medicine. Integrating PET and CT Information to Improve Diagnostic Accuracy for Lung Nodules: A Semiautomatic Computer-Aided Method More recent work on AI-driven risk stratification tools has shown the ability to appropriately downgrade some nodules from PET referral to simple follow-up and to upgrade others from surveillance to immediate PET, potentially improving the efficiency of the whole evaluation pipeline.19PubMed. A CADx tool improves lung nodule risk stratification when compared to British Thoracic Society guidelines on routine computed tomography These tools work best as decision support rather than replacements for clinical judgment, but they hint at a future where PET results are interpreted in a richer, more individualized context.
Practical Advice for Patients
If you have been told a lung nodule lit up on a PET scan, here are the things worth keeping in mind. First, a positive PET result is not a diagnosis. It is a piece of the puzzle, and for nodules in the uncertain zone, doctors combine it with everything else they know about you. Second, your infection and inflammatory history matters more than you might think. If you have lived in an area where fungal lung infections are common, have a history of tuberculosis, or have an autoimmune condition like rheumatoid arthritis or sarcoidosis, make sure your medical team knows. Those details directly change how a PET result should be interpreted.
Third, size affects reliability. For very small nodules, a PET scan is often not the best tool, and a strategy of watching with serial CT scans may be more appropriate. Fourth, if your scan result is ambiguous, ask whether dual-time-point imaging or additional evaluation might be worthwhile before moving to biopsy. Not every center offers it, but in the right circumstances it can provide meaningful additional information. Finally, getting a second read from a radiologist experienced with lung nodules is reasonable when the stakes are high. PET interpretation involves judgment calls, and expertise matters.
False Negatives Are Real Too
Most of the attention around PET accuracy focuses on false positives, but the reverse also happens. Some cancers do not light up. Certain slow-growing malignancies, like some subtypes of adenocarcinoma (particularly those with a ground-glass appearance on CT), have low metabolic activity and may fall below the 2.5 threshold. One study found that standard PET scanning missed roughly one in five malignant nodules at the 2.5 cutoff, giving a sensitivity of 80% rather than the 100% patients might hope for.11Journal of Nuclear Medicine. Dual Time Point 18F-FDG PET for the Evaluation of Pulmonary Nodules Other studies have reported sensitivity figures ranging from roughly 77% to over 90%, depending on the patient population and nodule characteristics.2PubMed Central. Relation between nodule size and 18F-FDG-PET SUV for malignant and benign pulmonary nodules
This means a “cold” PET scan does not guarantee a nodule is benign, especially if other features (irregular borders, growth on serial imaging, or a strong smoking history) raise suspicion. A PET scan is one of the best noninvasive tools available for evaluating lung nodules, but it is an imperfect one, and both patients and clinicians benefit from understanding that imperfection runs in both directions.